Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke: A STROKOG Collaboration Study

BACKGROUND AND PURPOSE—Type 2 diabetes mellitus (T2D) is associated with cognitive impairment and an increased risk of dementia, but the association between prediabetes and cognitive impairment is less clear, particularly in a setting of major cerebrovascular events. This article examines the impact...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke (1970) 2020-06, Vol.51 (6), p.1640-1646
Hauptverfasser: Lo, Jessica W., Crawford, John D., Samaras, Katherine, Desmond, David W., Köhler, Sebastian, Staals, Julie, Verhey, Frans R.J., Bae, Hee-Joon, Lee, Keon-Joo, Kim, Beom Joon, Bordet, Régis, Cordonnier, Charlotte, Dondaine, Thibaut, Mendyk, Anne-Marie, Lee, Byung-Chul, Yu, Kyung-Ho, Lim, Jae-Sung, Kandiah, Nagaendran, Chander, Russell J., Yatawara, Chathuri, Lipnicki, Darren M., Sachdev, Perminder S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND AND PURPOSE—Type 2 diabetes mellitus (T2D) is associated with cognitive impairment and an increased risk of dementia, but the association between prediabetes and cognitive impairment is less clear, particularly in a setting of major cerebrovascular events. This article examines the impact of impaired fasting glucose and T2D on cognitive performance in a stroke population. METHODS—Seven international observational studies from the STROKOG (Stroke and Cognition) consortium (n=1601; mean age, 66.0 years; 70% Asian, 26% white, and 2.6% African American) were included. Fasting glucose level (FGL) during hospitalization was used to define 3 groups, T2D (FGL ≥7.0 mmol/L), impaired fasting glucose (FGL 6.1–6.9 mmol/L), and normal (FGL
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.119.028428